SHALBY.NS Stock Analysis
SH
Neutral
Based on Eyestock quantitative analysis, SHALBY.NS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Shalby Ltd. engages in the operation of hospitals and outpatient clinics. The company is headquartered in Ahmedabad, Gujarat and currently employs 2,678 full-time employees. The company went IPO on 2017-12-15. The firm is mainly engaged in the business of setting up and managing hospitals and medical diagnostic services. Its Healthcare Services segment includes the business of setting up and managing hospitals and medical diagnostics services. Its Manufacturing segment represents the manufacturing of implants. The firm encompasses a range of specialties, which include joint replacement surgery, critical care and trauma, spine surgery, neurology, and neurosurgery, ortho-oncology, cardiology and minimally invasive cardiac surgery, sports injury, kidney transplant, liver transplant, hepato-biliary surgery, pediatrics, medical oncology and once-surgery, dental cosmetics and implantology, ophthalmology, plastic and reconstructive surgery, rheumatology, cosmetics and dermatology, homecare, bariatric surgery, gynecology, in vitro fertilization (IVF) and surrogacy counseling, homecare, among others.